Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

Azad, Arun A.; Armstrong, Andrew J.; Alcaraz, Antonio; Szmulewitz, Russell Z.; Petrylak, Daniel P.; Holzbeierlein, Jeffrey; Villers, Arnauld; Alekseev, Boris; Iguchi, Taro; Shore, Neal D.; Gomez-Veiga, Francisco; Rosbrook, Brad; Lee, Ho-Jin; Haas, Gabriel P.; Stenzl, Arnulf

dc.contributor.author	Stenzl, Arnulf
dc.date.accessioned	2023-02-06T15:40:58Z
dc.date.available	2023-02-06T15:40:58Z
dc.date.issued	2022
dc.identifier.issn	1365-7852
dc.identifier.uri	http://hdl.handle.net/10900/136211
dc.language.iso	en	de_DE
dc.publisher	Springernature	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41391-021-00436-y
dc.subject.ddc	610	de_DE
dc.title	Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_03040
utue.publikation.seiten	274-282	de_DE
utue.personen.roh	Azad, Arun A.
utue.personen.roh	Armstrong, Andrew J.
utue.personen.roh	Alcaraz, Antonio
utue.personen.roh	Szmulewitz, Russell Z.
utue.personen.roh	Petrylak, Daniel P.
utue.personen.roh	Holzbeierlein, Jeffrey
utue.personen.roh	Villers, Arnauld
utue.personen.roh	Alekseev, Boris
utue.personen.roh	Iguchi, Taro
utue.personen.roh	Shore, Neal D.
utue.personen.roh	Gomez-Veiga, Francisco
utue.personen.roh	Rosbrook, Brad
utue.personen.roh	Lee, Ho-Jin
utue.personen.roh	Haas, Gabriel P.
utue.personen.roh	Stenzl, Arnulf
dcterms.isPartOf.ZSTitelID	Prostate Cancer and Prostatic Diseases	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	25	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)